In addition to aberrant transforming growth factor-β (TGF-β) signaling, Habashi et al. (19) identified that blockade of the Ang II (ANG) type 1a receptor (AT1aR) inhibited TAA development in a murine model of MFS. This evidence concerns the gene AGTR1 and Marfan syndrome.